DIAGNOS Inc. (DGNOF) Research

DIAGNOS Inc. specializes in delivering technology-driven services, with its reach primarily extending across Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. A cornerstone of its offerings is Computer Assisted Retina Analysis (CARA), a web-based software application in the healthcare sector. This innovative tool is designed to aid medical professionals in identifying diabetic retinopathy, empowering eye care specialists to clearly visualize both normal anatomical features of the retina and any disease-related changes. Beyond its medical applications, the company also furnishes expert consulting services in the domains of data analytics and artificial intelligence. Established in 1998, DIAGNOS maintains its principal office in Brossard, Canada.

Market snapshot

Symbol
DGNOF
Price
$0.15
Day change
0.00%
Market cap
$22.9M
P/E ratio
-5.95x
52-week range
0.13-0.29
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months

Peer companies

  • Alternate Health Corp. (AHGIF)
  • Bonus BioGroup Ltd. (BBIXF)
  • BioMark Diagnostics Inc. (BMKDF)
  • Cordlife Group Limited (CLIFF)
  • Celyad Oncology S.A. (CLYYF)
  • CareView Communications, Inc. (CRVW)
  • ImpediMed Limited (IPDQF)
  • Marpai, Inc. (MRAI)

Open DIAGNOS Inc. (DGNOF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.